<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02162121</url>
  </required_header>
  <id_info>
    <org_study_id>IOGPGC06-14</org_study_id>
    <nct_id>NCT02162121</nct_id>
  </id_info>
  <brief_title>Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?</brief_title>
  <official_title>Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ASST Gaetano Pini-CTO</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ASST Gaetano Pini-CTO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stimulating catheters have been introduced to reduce the incidence of secondary failure after
      continuous peripheral nerve blocks, but they effectiveness over traditional nonstimulating
      catheters is still controversial. The aim of this prospective, randomized, blinded study is
      to detect if stimulating catheters improve postoperative compared with conventional
      non-stimulating catheters.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local anesthetic consumption</measure>
    <time_frame>72h</time_frame>
    <description>Evaluation of local anesthesic consumption every 6h in first 72 postoperative hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog scale (VAS) score</measure>
    <time_frame>72h postoperatively</time_frame>
    <description>Evaluation of VAS static and VAS dynamic during first 72 postoperative hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Up and Go test</measure>
    <time_frame>4th postoperative day</time_frame>
    <description>&quot;up and go&quot; test: time need to get up from a chair, walk for 3 meters, and come back to seat down on the chair</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioids request</measure>
    <time_frame>72h postoperatively</time_frame>
    <description>Opioids consumption will be recorded throughout 72 postoperative hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps strength</measure>
    <time_frame>preoperative and 24h, 48h, 72h postoperatively</time_frame>
    <description>evaluate bilateral muscle strength with an isometric force dynamometer to measure the force produced during a maximum voluntary isometric contraction in a lying position by the knee flex to 90Â°.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative nausea and vomiting (PONV)</measure>
    <time_frame>72h postoperatively</time_frame>
    <description>Evaluation of nausea and vomit incidence in postoperative period with scale 0 from 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Needle redirections</measure>
    <time_frame>During catheter position</time_frame>
    <description>During catheter positioning number of needle redirections necessary to found lumbar plexus are recorder.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catheter insertion time</measure>
    <time_frame>During catheter positioning</time_frame>
    <description>Time (minutes) needed for catheter placement</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Hip Replacement Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After Spinal Anesthesia (Levobupivacaine 0,5% 15mg) all patients in the arm will receive continuous lumbar plexus block with stimulating catheter (&quot;Stimolong&quot;, &quot;Pajunk&quot;, Germany). Mepivacaine 1% 15 ml will be administrated. As post-operative analgesia Ropivacaine 0,2% will be continuous administrated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After Spinal Anesthesia (levobupivacaine 0,5% 15mg) all patients in the arm will receive continuous lumbar plexus block with non-stimulating catheter (&quot;Stimolong&quot;, &quot;Pajunk&quot;, Germany). Mepivacaine 1% 15ml will be administrated. As post-operative analgesia Ropivacaine 0,2% will be continuous administrated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous lumbar plexus: stimulating catheter</intervention_name>
    <description>Perinervous stimulating catheter (&quot;Stimulong&quot;, &quot;Pajunk&quot;, Germany) will be insert in lumbar plexus through tuohy needle (18G, 100mm length). 15ml mepivacaine 1% are injected before the complete resolution of the spinal anesthesia.</description>
    <arm_group_label>Stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal Anesthesia</intervention_name>
    <description>Spinal anesthesia will be perform at L3-L4 or L4-L5 level. Levobupivacaine 0,5% 15mg will be injected.</description>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local anesthetic infusion</intervention_name>
    <description>Continuous infusion (Mini Rythmic Evolution, Micrel) of ropivacaine 0,2% at 3ml/h, bolus 3 ml, lockout time 15 min, 12 ml/h maximum dose through perinervous catheter until 3rd postoperative day</description>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intravenous analgesia</intervention_name>
    <description>Ketorolac 30mg 3 times a day</description>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Opioids rescue analgesia</intervention_name>
    <description>Buprenorphine 0,2mg twice a day if VAS&gt;4</description>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mepivacaine 1%</intervention_name>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine 0,5%</intervention_name>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0,2%</intervention_name>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac 30mg</intervention_name>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buprenorphine 0,2mg</intervention_name>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stimulong, Pajunk, Germany.</intervention_name>
    <arm_group_label>Stimulating catheter</arm_group_label>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous lumbar plexus: non-stimulating catheter</intervention_name>
    <arm_group_label>Non-stimulating catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing total hip arthroplasty

        Exclusion Criteria:

          -  diabetes neurological disorders coagulation disorders rheumatoid arthritis chronic
             opioids therapy allergy to local anesthetic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Cappelleri, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>ASST Gaetano Pini-CTO</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istituto ortopedico Gaetano Pini</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2014</study_first_submitted>
  <study_first_submitted_qc>June 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2014</study_first_posted>
  <last_update_submitted>August 11, 2017</last_update_submitted>
  <last_update_submitted_qc>August 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ASST Gaetano Pini-CTO</investigator_affiliation>
    <investigator_full_name>Gianluca Cappelleri</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Mepivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Buprenorphine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

